Indomethacin for refractory COVID or post-COVID headache: a retrospective study

BACKGROUND: COVID-19, a disease caused by SARS-CoV-2, manifests with headache, both in the acute phase and as a post-infection symptom, which may be refractory to usual analgesics. OBJECTIVES: Investigate the therapeutic response of refractory COVID or post-COVID headache to indomethacin. METHODS: T...

Descripción completa

Detalles Bibliográficos
Autores principales: Krymchantowski, Abouch V., Silva-Néto, Raimundo Pereira, Jevoux, Carla, Krymchantowski, Ana Gabriela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8453033/
https://www.ncbi.nlm.nih.gov/pubmed/34546559
http://dx.doi.org/10.1007/s13760-021-01790-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8453033/
https://www.ncbi.nlm.nih.gov/pubmed/34546559
http://dx.doi.org/10.1007/s13760-021-01790-3

Ejemplares similares